Previous 10 | Next 10 |
home / stock / aqs:cc / aqs:cc news
(TheNewswire) Vancouver, BC - TheNewswire - November 29, 2023 - Aequus Pharmaceuticals Inc. (TSX-V:AQS ) ( OTC:AQSZF) (“ Aequus ” or the “ Company ”), a specialty pharmaceutical company with a focus on developing, a...
(TheNewswire) Vancouver, BC - TheNewswire - October 20, 2023 - Aequus Pharmaceuticals Inc. (TSX-V:AQS ) ( OTC: AQSZF) (“ Aequus ” or the “ Company ”), announces today it has increased its debt by $1,000,000 to suppo...
(TheNewswire) VANCOUVER, BC – TheNewswire - October 6, 2023 - Aequus Pharmaceuticals Inc. (TSXV:AQS ) , ( OTC:AQSZF) (“Aequus” or the “Company”), announces today it has increased its debt by $270,000 to support operating costs a...
VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing, and promoting differentiated products, today rep...
VANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ), ) (“Aequus” or the “Company”), a specialty pharmaceutical company announced today, we are thrilled to announce the launch of Zimed &...
VANCOUVER, British Columbia, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ), ) (“Aequus” or the “Company”), a specialty pharmaceutical company, are thrilled to announce the launch of our user friendly education websit...
VANCOUVER, British Columbia, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ), ) (“Aequus” or the “Company”), a specialty pharmaceutical company announces the pause of sales of its Evolve Intensive eyedrop and Intensive...
VANCOUVER, British Columbia, July 06, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announces today it has increased its debt by $400,000 to support the launch of Zimed ® PF. Mr. Doug Janzen, Chair...
VANCOUVER, British Columbia, May 30, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today repor...
VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company focused on bringing healthcare solutions to Canadians through licensing and partnerships...
News, Short Squeeze, Breakout and More Instantly...
Aequus Pharmaceuticals Inc. Company Name:
AQS:CC Stock Symbol:
TSXVC Market:
(TheNewswire) VANCOUVER – TheNewswire - May 22, 2024 – Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company focused on bringing healthcare solutions to Canadians through licen...
Aequus Pharmaceuticals Inc. (AQS:CA) is expected to report for Q1 2024
(TheNewswire) VANCOUVER, May 09, 2024 – TheNewswire – Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company focused on bringing healthcare solutions to Canadians through licens...